[HTML][HTML] Inclisiran in lipid management: a literature overview and future perspectives
P Scicchitano, M Milo, R Mallamaci, M De Palo… - Biomedicine & …, 2021 - Elsevier
Primary and secondary prevention protocols aim at reducing the plasma levels of lipids-with
particular reference to low-density lipoprotein cholesterol (LDL-C) plasma concentrations–in …
particular reference to low-density lipoprotein cholesterol (LDL-C) plasma concentrations–in …
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Aim The aim of the European Action on Secondary and Primary Prevention by Intervention
to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European …
to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European …
Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on …
K Kotseva, D De Bacquer, G De Backer… - European journal of …, 2016 - academic.oup.com
Abstract Background European Action on Secondary and Primary Prevention by Intervention
to Reduce Events (EUROASPIRE) IV in primary care was a cross-sectional survey carried …
to Reduce Events (EUROASPIRE) IV in primary care was a cross-sectional survey carried …
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
K Kotseva, D Wood, G De Backer… - European Journal of …, 2010 - academic.oup.com
Objective To determine whether the 2003 Joint European Societies' guidelines on
cardiovascular disease prevention in people at high cardiovascular risk have been followed …
cardiovascular disease prevention in people at high cardiovascular risk have been followed …
Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis
JD Spence, DG Hackam - Stroke, 2010 - Am Heart Assoc
Background and Purpose—Until recently, atherosclerosis was thought to be inexorably
progressive. Beginning in 2001 and implemented in our vascular prevention clinics by 2003 …
progressive. Beginning in 2001 and implemented in our vascular prevention clinics by 2003 …
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
FE Cotté, P Fardellone, F Mercier, AF Gaudin… - Osteoporosis …, 2010 - Springer
This primary care database survey evaluated whether osteoporotic women treated with
bisphosphonates were more adherent to monthly than to weekly treatment. Both compliance …
bisphosphonates were more adherent to monthly than to weekly treatment. Both compliance …
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
S Rollefstad, TK Kvien, I Holme, AS Eirheim… - Annals of the …, 2013 - ard.bmj.com
Objectives To perform cardiovascular risk stratification in patients with inflammatory joint
diseases (IJD) and treat to lipid targets according to recommendations. Methods We initiated …
diseases (IJD) and treat to lipid targets according to recommendations. Methods We initiated …
Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects
N Plana, C Nicolle, R Ferre, J Camps, R Cos… - European Journal of …, 2008 - Springer
Background The number of hypercholesterolemic individuals who do not meet their
cholesterol recommended targets is inappropriately high. The use of plant sterol-enriched …
cholesterol recommended targets is inappropriately high. The use of plant sterol-enriched …
Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
N Goldenberg, C Glueck - Vascular health and risk management, 2009 - Taylor & Francis
Statins became available for the treatment of hypercholesterolemia in 1987. Multiple, well-
designed, placebo-controlled, double-blind studies revealed that each 1% reduction in …
designed, placebo-controlled, double-blind studies revealed that each 1% reduction in …
Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis
AK Chhatriwalla, SJ Nicholls, TH Wang… - Journal of the American …, 2009 - jacc.org
Objectives: We investigated coronary atheroma progression in patients with low levels of low-
density lipoprotein cholesterol (LDL-C) and systolic blood pressure (SBP). Background: Low …
density lipoprotein cholesterol (LDL-C) and systolic blood pressure (SBP). Background: Low …